Career Opportunities

Cybrexa
Cybrexa
bioscience
therapeutics

Cybrexa is a privately-held biotechnology company dedicated to developing next-generation tumor-targeted cancer therapies using its alphalex™ platform. The Company’s lead candidate, CBX-12, an alphalex™-exatecan conjugate, is expected to enter Phase I in 2021 in advanced solid tumors. Cybrexa also has other preclinical toxin conjugate programs as well as synthetic lethality programs. Cybrexa was founded by physician-scientists and has an experienced management team that has built numerous successful life sciences companies.
cybrexa.com
New Haven, CT, USA
Founded in 2017
Inaccurate data? Flag it here.
Open jobs at Cybrexa
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Connecticut Innovations to understand how it is being used. Read our Cookie Policy.